These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30125379)

  • 1. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study.
    Hajifathalian K; Torabi Sagvand B; McCullough AJ
    Hepatology; 2019 Aug; 70(2):511-521. PubMed ID: 30125379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
    Janjua M; Knuiman M; Divitini M; McQuillan B; Olynyk JK; Jeffrey GP; Adams LA
    Hepatol Commun; 2022 Mar; 6(3):526-534. PubMed ID: 34931492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
    Ajmera V; Belt P; Wilson LA; Gill RM; Loomba R; Kleiner DE; Neuschwander-Tetri BA; Terrault N;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1511-1520.e5. PubMed ID: 29378307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States.
    Wijarnpreecha K; Scribani M; Kim D; Kim WR
    Liver Int; 2019 Jul; 39(7):1202-1206. PubMed ID: 30697898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up.
    Alvarez CS; Graubard BI; Thistle JE; Petrick JL; McGlynn KA
    Hepatology; 2020 Aug; 72(2):430-440. PubMed ID: 31733165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
    Xu L; Xie J; Chen S; Chen Y; Yang H; Miao M; Zhu Z; Li Y; Yu C; Xu C
    Am J Gastroenterol; 2020 Jun; 115(6):876-884. PubMed ID: 32282335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.
    Long MT; Massaro JM; Hoffmann U; Benjamin EJ; Naimi TS
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1831-1841.e5. PubMed ID: 31734449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the Tianjin Chronic Low-grade Systemic Inflammation and Health Cohort Study.
    Zhang S; Gan S; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Gu Y; Wang Y; Zhang T; Wang X; Sun S; Wang X; Zhou M; Jia Q; Song K; Qi L; Niu K
    Int J Epidemiol; 2022 Feb; 51(1):237-249. PubMed ID: 34528679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).
    Golabi P; Stepanova M; Pham HT; Cable R; Rafiq N; Bush H; Gogoll T; Younossi ZM
    BMJ Open Gastroenterol; 2018; 5(1):e000198. PubMed ID: 29607054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease.
    Dunn W; Xu R; Schwimmer JB
    Hepatology; 2008 Jun; 47(6):1947-54. PubMed ID: 18454505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
    Johnston MP; Patel J; Byrne CD
    Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol consumption and mortality after breast cancer diagnosis: The health and functioning in women study.
    Din N; Allen IE; Satariano WA; Demb J; Braithwaite D
    Breast Dis; 2016 Jul; 36(2-3):77-89. PubMed ID: 27662274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease.
    Zheng T; Wang X; Kamili K; Luo C; Hu Y; Wang D; Wang B; Gao P; Tian G
    Scand J Gastroenterol; 2024 Apr; 59(4):480-488. PubMed ID: 38179969
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and risk factors of fatty liver in Portuguese adults.
    Leitão J; Carvalhana S; Cochicho J; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Oliveiros B; Rodrigues V; Sousa R; Sampaio F; Carvalho A; Cortez-Pinto H
    Eur J Clin Invest; 2020 Jun; 50(6):e13235. PubMed ID: 32289180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Statin Use on Cancer-related Mortality in Nonalcoholic Fatty Liver Disease: A Prospective United States Cohort Study.
    Hajifathalian K; Tafesh Z; Rosenblatt R; Kumar S; Homan EA; Sharaiha RZ; Cohen DE; Brown RS; Fortune BE
    J Clin Gastroenterol; 2022 Feb; 56(2):173-180. PubMed ID: 33606428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease is not associated with a lower health perception.
    Mlynarsky L; Schlesinger D; Lotan R; Webb M; Halpern Z; Santo E; Shibolet O; Zelber-Sagi S
    World J Gastroenterol; 2016 May; 22(17):4362-72. PubMed ID: 27158205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.
    Chang Y; Cho YK; Kim Y; Sung E; Ahn J; Jung HS; Yun KE; Shin H; Ryu S
    Hepatology; 2019 Jan; 69(1):64-75. PubMed ID: 30019340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
    Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
    Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.